Outcomes of Intensifying Older Adults’ Antihypertensive Regimens at Hospital Discharge
This cohort study investigates the association between intensification of antihypertensive regimens at hospital discharge and clinical outcomes after discharge.
This cohort study investigates the association between intensification of antihypertensive regimens at hospital discharge and clinical outcomes after discharge.
This study uses US Food and Drug Administration (FDA) data to characterize pivotal and confirmatory trials supporting agency decision-making in the context of the FDA…
This cohort study analyzes electronic health record data for patients with idiopathic intracranial hypertension to assess whether therapy with glucagon-like peptide 1 receptor agonists is…
This cohort study analyzes electronic health record data for patients with idiopathic intracranial hypertension to assess whether therapy with glucagon-like peptide 1 receptor agonists is…
This Viewpoint explores the US Food and Drug Administration’s institution of a class Safety Labeling Change for messenger RNA (mRNA) COVID-19 vaccines.
Ever wonder what happens to your manuscript after you submit it? From manuscript submission and peer review to all the ways we improve and promote…
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
This cohort study analyzes electronic health record data for patients with idiopathic intracranial hypertension to assess whether therapy with glucagon-like peptide 1 receptor agonists is…
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
This cross-sectional study assesses trends in emergency department encounters for cannabis hyperemesis syndrome among adolescents.